In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Estrella Immunopharma Inc (NASDAQ: ESLA) was $0.99 for the day, up 2.47% from the previous closing price of $0.97. In other words, the price has increased by $2.47 from its previous closing price. On the day, 0.12 million shares were traded. ESLA stock price reached its highest trading level at $1.0499 during the session, while it also had its lowest trading level at $0.99.
Ratios:
Our analysis of ESLA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.15 and its Current Ratio is at 0.15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESLA now has a Market Capitalization of 37538996 and an Enterprise Value of 35916384.
Stock Price History:
The Beta on a monthly basis for ESLA is 0.54, which has changed by -0.14310342 over the last 52 weeks, in comparison to a change of 0.14725316 over the same period for the S&P500. Over the past 52 weeks, ESLA has reached a high of $3.15, while it has fallen to a 52-week low of $0.73. The 50-Day Moving Average of the stock is -42.99%, while the 200-Day Moving Average is calculated to be -22.07%.
Shares Statistics:
ESLA traded an average of 256.14K shares per day over the past three months and 109710 shares per day over the past ten days. A total of 37.77M shares are outstanding, with a floating share count of 13.01M. Insiders hold about 69.06% of the company’s shares, while institutions hold 1.77% stake in the company. Shares short for ESLA as of 1767139200 were 738819 with a Short Ratio of 2.88, compared to 1764288000 on 551846. Therefore, it implies a Short% of Shares Outstanding of 738819 and a Short% of Float of 6.3200004000000005.
